Geron
GERN
#6435
Rank
NZ$1.63 B
Marketcap
NZ$2.55
Share price
-1.31%
Change (1 day)
2.39%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -NZ$60.93 Million

According to Geron's latest financial reports the company's current earnings are NZ$0.19 Billion. In 2025 the company made an earning of -NZ$85.94 Million, an increase over its 2024 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$60.93 Million-29.11%
2025 -NZ$85.94 Million-67.42%
2024 -NZ$0.27 Billion-11.23%
2023 -NZ$0.3 Billion30.22%
2022 -NZ$0.23 Billion20.15%
2021 -NZ$0.19 Billion50.08%
2020 -NZ$0.13 Billion4.46%
2019 -NZ$0.13 Billion130.68%
2018 -NZ$52.53 Million8.84%
2017 -NZ$48.26 Million-3.08%
2016 -NZ$49.79 Million-22080.6%
2015 NZ$0.22 M-100.38%
2014 -NZ$60.16 Million-7.14%
2013 -NZ$64.78 Million
2011 -NZ$0.16 Billion19.04%
2010 -NZ$0.13 Billion8.45%
2009 -NZ$0.12 Billion-2.51%
2008 -NZ$0.13 Billion14.65%
2007 -NZ$0.11 Billion32.68%
2006 -NZ$80.06 Million25.59%
2005 -NZ$63.75 Million4.36%
2004 -NZ$61.08 Million19.73%
2003 -NZ$51.02 Million-15.46%
2002 -NZ$60.35 Million1.94%
2001 -NZ$59.2 Million33.59%
2000 -NZ$44.31 Million27.53%
1999 -NZ$34.75 Million63.13%
1998 -NZ$21.3 Million15.6%
1997 -NZ$18.43 Million-10.66%
1996 -NZ$20.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$18.13 B-30,147.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$2.99 B-5,068.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.12 Billion 93.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.26 B-539.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$25.22 Million-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA